Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice
Liver International · 2024
DOI: 10.1111/liv.16004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Rocío Brea und 18 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain. Hauptthemen laut MEDLINE: Bile Acids and Salts, Cholestasis, Common Bile Duct, Cyclooxygenase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación/10.13039/501100011033, Agencia Nacional de Promoción Científica y Tecnológica, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Background and Aims Cyclooxygenase‐2 (COX‐2) is involved in different liver diseases, but little is known about the significance of COX‐2 in cholestatic injury. This study was designed to elucidate the role of COX‐2 expression in hepatocytes during the pathogenesis of obstructive cholestasis.
Methods
We used genetically modified mice constitutively expressing human COX‐2 in hepatocytes. Transgenic mice ( hCOX‐2‐Tg ) and their wild‐type ( Wt ) littermates were either subjected to a mid‐abdominal laparotomy or common bile duct ligation (BDL) for 2 or 5 days. Then, we explored the mechanisms underlying the role of COX‐2 and its derived prostaglandins in liver function, and the synthesis and excretion of bile acids (BA) in response to cholestatic liver injury.
Results
After BDL, hCOX‐2‐Tg mice showed lower grades of hepatic necrosis and inflammation than Wt mice, in part by a reduced hepatic neutrophil recruitment associated with lower mRNA levels of pro‐inflammatory cytokines. Furthermore, hCOX‐2‐Tg mice displayed a differential metabolic pattern of BA synthesis that led to an improved clearance after BDL‐induced accumulation. In addition, an enhanced response to the BDL‐induced oxidative stress and hepatic apoptosis was observed. In vitro experiments using hepatic cells that stably express hCOX‐2 confirmed the cytoprotective role of prostaglandin E 2 against BA toxicity.
Conclusions
Taken together, our data indicate that constitutive expression of COX‐2 in hepatocytes ameliorates cholestatic liver injury in mice by reducing inflammation and cell damage and by modulating BA metabolism, pointing to a role for COX‐2 as a defensive response against cholestasis‐derived BA accumulation and injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain.
- Instituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
- Instituto de Fisiología Experimental (IFISE-CONICET), Rosario, Argentina.
- Cátedra de Histología y Embriología Humana-Fac. Cs. Médicas-UNR, Rosario, Argentina.
- IIS-Hospital La Fe, Valencia, Spain.
ORCID-Profile: Rocío Brea, Natalia Casanova, Carlota Alvarez-Lucena, Marina Fuertes-Agudo, María Luque-Tevar, Carme Cucarella, María C Capitani, María V Marinochi, Matías E Fusini, Agustín Lahoz, Marina López Nogueroles, Juan Fraile, María T Ronco, Lisardo Boscá, Águeda González-Rodríguez, Carmelo García-Monzón, Paloma Martín-Sanz, Marta Casado, Daniel E Francés
Förderung
- Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación/10.13039/501100011033
- Agencia Nacional de Promoción Científica y Tecnológica
- Ministerio de Ciencia e Innovación
Zitieren
APA
Brea, R., Casanova, N., Alvarez-Lucena, C., Fuertes-Agudo, M., Luque-Tevar, M., Cucarella, C., Capitani, M. C., Marinochi, M. V., Fusini, M. E., Lahoz, A., Nogueroles, M. L., Fraile, J., Ronco, M. T., Boscá, L., González-Rodríguez, Á., García-Monzón, C., Martín-Sanz, P., Casado, M., & Francés, D. E. (2024). Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice. Liver International. https://doi.org/10.1111/liv.16004
Vancouver
Brea R, Casanova N, Alvarez-Lucena C, Fuertes-Agudo M, Luque-Tevar M, Cucarella C, et al. Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice. Liver International. 2024. doi:10.1111/liv.16004
BibTeX
@article{Brea2024,
author = {Brea, Rocío and Casanova, Natalia and Alvarez-Lucena, Carlota and Fuertes-Agudo, Marina and Luque-Tevar, María and Cucarella, Carme and Capitani, María C and Marinochi, María V and Fusini, Matías E and Lahoz, Agustín and Nogueroles, Marina López and Fraile, Juan and Ronco, María T and Boscá, Lisardo and González-Rodríguez, Águeda and García-Monzón, Carmelo and Martín-Sanz, Paloma and Casado, Marta and Francés, Daniel E},
title = {Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16004}
}
EUVIMED